Literature DB >> 18828016

Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.

Xuede Lin1, Xiaojian Wang, Haley L Capek, Laura C Simone, Amit Tuli, Chantey R Morris, Adrian J Reber, Joyce C Solheim.   

Abstract

Invariant chain (Ii) binds to the human leukocyte antigen (HLA) class II molecule and assists it in the process of peptide acquisition. In addition, Ii binds to the HLA class I molecule, although there has been little study of its effects on the HLA class I molecule. In addition to its normal expression on antigen-presenting cells, Ii expression is up regulated in a variety of tumors. By flow cytometric analysis, we found that expression of Ii resulted in an increase in the number of cell surface HLA class I molecules and in the proportion of unstable HLA class I molecules at the surface of breast tumor cell lines. These data suggest that the expression of Ii by tumor cells may quantitatively and qualitatively alter the presentation of antigens on those cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18828016      PMCID: PMC2703440          DOI: 10.1007/s00262-008-0595-1

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  40 in total

1.  Analysis of major histocompatibility complex class I interactions with endoplasmic reticulum proteins.

Authors:  H R Turnquist; J C Solheim
Journal:  Methods Mol Biol       Date:  2001

2.  Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.

Authors:  Adrian J Reber; Hēth R Turnquist; Heather J Thomas; Charles T Lutz; Joyce C Solheim
Journal:  Immunogenetics       Date:  2002-03-23       Impact factor: 2.846

3.  Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy.

Authors:  Antoni Ribas; John A Glaspy; Yohan Lee; Vivian B Dissette; Elisabeth Seja; Huong T Vu; N Simon Tchekmedyian; Denise Oseguera; Begonya Comin-Anduix; Jennifer A Wargo; Saral N Amarnani; William H McBride; James S Economou; Lisa H Butterfield
Journal:  J Immunother       Date:  2004 Sep-Oct       Impact factor: 4.456

4.  Epithelial cell cultures from normal and cancerous human tissues.

Authors:  R B Owens; H S Smith; W A Nelson-Rees; E L Springer
Journal:  J Natl Cancer Inst       Date:  1976-04       Impact factor: 13.506

5.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

6.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

7.  Isolation of a human prostate carcinoma cell line (DU 145).

Authors:  K R Stone; D D Mickey; H Wunderli; G H Mickey; D F Paulson
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

8.  Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.

Authors:  R Cailleau; M Olivé; Q V Cruciger
Journal:  In Vitro       Date:  1978-11

9.  Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.

Authors:  A N Young; M B Amin; C S Moreno; S D Lim; C Cohen; J A Petros; F F Marshall; A S Neish
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 10.  Determinant spreading and tumor responses after peptide-based cancer immunotherapy.

Authors:  Antoni Ribas; John M Timmerman; Lisa H Butterfield; James S Economou
Journal:  Trends Immunol       Date:  2003-02       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.